Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2018
Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis
Alessandro Prete, Agnes S Lo, Peter M Sadow, et al.
Clinical Endocrinology
|
May 16, 2025
Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease Control
Richard John M Ross, Wiebke Arlt, Aude Brac de la Perriere, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 2, 2021
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Deborah P Merke, Ashwini Mallappa, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 15, 2020
Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery
Alessandro Prete, Angela E Taylor, Irina Bancos, et al.
European Journal of Endocrinology
|
January 19, 2023
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia
Lea Tschaidse, Nicole Reisch, Wiebke Arlt, et al.
Ebiomedicine
|
May 21, 2025
Modelling adrenal steroid profiles to inform monitoring guidance in congenital adrenal hyperplasia
Neil R Lawrence, Jeremy Dawson, Zi-Qiang Lang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 2019
Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency
Riccardo Pofi, Alessandro Prete, Vivien Thornton-Jones, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis
Vasileios Chortis, Kleiton Silva Borges, Cong-Hui Yao, et al.
Nature Medicine
|
January 16, 2023
[<sup>11</sup>C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial
Xilin Wu, Russell Senanayake, Emily Goodchild, et al.
Annals of Internal Medicine
|
January 3, 2022
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study
Alessandro Prete, Anuradhaa Subramanian, Irina Bancos, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2018
Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis
Alessandro Prete, Agnes S Lo, Peter M Sadow, et al.
Clinical Endocrinology
|
May 16, 2025
Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease Control
Richard John M Ross, Wiebke Arlt, Aude Brac de la Perriere, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 2, 2021
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Deborah P Merke, Ashwini Mallappa, Wiebke Arlt, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 15, 2020
Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery
Alessandro Prete, Angela E Taylor, Irina Bancos, et al.
European Journal of Endocrinology
|
January 19, 2023
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia
Lea Tschaidse, Nicole Reisch, Wiebke Arlt, et al.
Ebiomedicine
|
May 21, 2025
Modelling adrenal steroid profiles to inform monitoring guidance in congenital adrenal hyperplasia
Neil R Lawrence, Jeremy Dawson, Zi-Qiang Lang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 2019
Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency
Riccardo Pofi, Alessandro Prete, Vivien Thornton-Jones, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis
Vasileios Chortis, Kleiton Silva Borges, Cong-Hui Yao, et al.
Nature Medicine
|
January 16, 2023
[<sup>11</sup>C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial
Xilin Wu, Russell Senanayake, Emily Goodchild, et al.
Annals of Internal Medicine
|
January 3, 2022
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study
Alessandro Prete, Anuradhaa Subramanian, Irina Bancos, et al.
Page
of 11